MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-23-2026
Medpace Holdings Operating Cycle 2011-2026 | MEDP
Annual Operating Cycle Medpace Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50.4 | 51.5 | 53.4 | 55 | 55.5 | 62.4 | 66 | 69.1 | 69.5 | 69.1 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 69.5 | 50.4 | 60.2 |
Quarterly Operating Cycle Medpace Holdings
| 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51.4 | - | 51.9 | 51.1 | 48.6 | - | 52.4 | 50.1 | 51.6 | - | 52.6 | 52.8 | 53.7 | - | 29.6 | 29.2 | 56.7 | - | 53.7 | 52.7 | 56.3 | - | 63.8 | 71.7 | 62.6 | 61.8 | 65.7 | 66.3 | 65.7 | 63.4 | 67.9 | 71.6 | 60.6 | 67.3 | 68.5 | 71.4 | 69.7 | - | 67.5 | 68.7 | 66.4 | - | 32.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 71.7 | 29.2 | 57.9 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Castle Biosciences
CSTL
|
97.4 | $ 20.58 | -16.87 % | $ 597 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
275 | $ 17.01 | - | $ 179 M |  China |
 |
Agilent Technologies
A
|
161 | $ 118.71 | 0.87 % | $ 36.1 B | USA |
 |
Myriad Genetics
MYGN
|
95.1 | $ 4.13 | 0.36 % | $ 382 M | USA |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
NeoGenomics
NEO
|
102 | $ 9.09 | 2.25 % | $ 1.16 B | USA |
 |
National Research Corporation
NRC
|
29.4 | $ 17.74 | -0.67 % | $ 397 M | USA |
 |
Natera
NTRA
|
81.5 | $ 216.41 | 0.61 % | $ 21.3 B | USA |
 |
Aspira Women's Health
AWH
|
1.2 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 27.67 | 1.62 % | $ 26.2 B |  Niderland |
 |
Personalis
PSNL
|
55.8 | $ 6.09 | 0.25 % | $ 361 M | USA |
 |
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | USA |
 |
CareDx, Inc
CDNA
|
51.5 | $ 21.84 | 4.25 % | $ 1.16 B | USA |
 |
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | USA |
 |
Soleno Therapeutics
SLNO
|
1.04 K | $ 52.94 | -0.01 % | $ 2.69 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | USA |
 |
Co-Diagnostics
CODX
|
1.79 K | $ 1.73 | 5.45 % | $ 2.3 M | USA |
 |
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | China |
 |
Trinity Biotech plc
TRIB
|
299 | $ 0.61 | 0.53 % | $ 219 M |  Irlanda |
 |
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | USA |
 |
Twist Bioscience Corporation
TWST
|
96.1 | $ 58.99 | -0.91 % | $ 3.53 B | USA |
 |
Charles River Laboratories International
CRL
|
65 | $ 184.27 | 1.4 % | $ 9.13 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
91.7 | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 15.01 | 0.6 % | $ 454 M | USA |
 |
Guardant Health
GH
|
128 | $ 90.55 | -1.84 % | $ 11.4 B | USA |
 |
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
68.5 | $ 124.9 | 0.62 % | $ 10.3 B | Irlanda |
 |
Illumina
ILMN
|
198 | $ 139.88 | -1.89 % | $ 22.2 B | USA |
 |
Senseonics Holdings
SENS
|
104 | $ 5.32 | -0.84 % | $ 222 M | USA |
 |
Interpace Biosciences
IDXG
|
96 | $ 2.04 | -3.33 % | $ 9.02 M | USA |
 |
Waters Corporation
WAT
|
834 | $ 346.81 | -0.86 % | $ 20.7 B | USA |
 |
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
204 | $ 2.17 | -1.84 % | $ 4.98 M | USA |
 |
Thermo Fisher Scientific
TMO
|
70 | $ 473.95 | 0.12 % | $ 179 B | USA |
 |
Lantheus Holdings
LNTH
|
121 | $ 89.06 | 3.38 % | $ 6.01 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
71.8 | $ 256.98 | 0.02 % | $ 21.4 B | USA |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K |  Israel |
 |
Neogen Corporation
NEOG
|
213 | $ 9.15 | -0.33 % | $ 1.98 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
54.2 | $ 189.75 | 0.33 % | $ 21.1 B | USA |